M&R Capital Management’s Micron Technology MU Stock Holding History

M&R Capital Management’s Portfolio MU Stock Details MU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-140	Closed	-$8.84K	–	625
2023 Q2	$8.84K	Buy	+140	New	+$9K	﹤0.01%	397

Other funds holding MU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

M&R Capital Management's MU Position: Q3 2023 in Review

M&R Capital Management sold out of Micron Technology (MU) in Q3 2023, closing a stake of 140 shares — an estimated $8.84K sold.

M&R Capital Management first reported a position in MU in Q2 2023 and held it in 1 quarter. The position peaked at $8.84K in Q2 2023. 1,316 funds tracked by Wall St. Rank hold MU as of Q3 2023.

M&R Capital Management reported no remaining Micron Technology position as of Q3 2023 after selling out during the quarter.
M&R Capital Management sold 140 Micron Technology shares in Q3 2023, an estimated $8.84K.
M&R Capital Management first reported a position in Micron Technology in Q2 2023 and held it in 1 quarter.
M&R Capital Management's Micron Technology position peaked at $8.84K in Q2 2023.
1,316 funds tracked by Wall St. Rank held Micron Technology as of Q3 2023.

Based on M&R Capital Management's 13F filing for Q3 2023, filed 10 Oct 2023.